317 related articles for article (PubMed ID: 18096504)
21. Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes.
Saario SM; Salo OM; Nevalainen T; Poso A; Laitinen JT; Järvinen T; Niemi R
Chem Biol; 2005 Jun; 12(6):649-56. PubMed ID: 15975510
[TBL] [Abstract][Full Text] [Related]
22. Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors.
Goparaju SK; Ueda N; Taniguchi K; Yamamoto S
Biochem Pharmacol; 1999 Feb; 57(4):417-23. PubMed ID: 9933030
[TBL] [Abstract][Full Text] [Related]
23. Modulation of the anti-nociceptive effects of 2-arachidonoyl glycerol by peripherally administered FAAH and MGL inhibitors in a neuropathic pain model.
Desroches J; Guindon J; Lambert C; Beaulieu P
Br J Pharmacol; 2008 Nov; 155(6):913-24. PubMed ID: 18695638
[TBL] [Abstract][Full Text] [Related]
24. Monoacylglycerol lipase inhibitor protects primary cultured neurons against homocysteine-induced impairments in rat caudate nucleus through COX-2 signaling.
Dong M; Lu Y; Zou Z; Yang H
Life Sci; 2015 Oct; 138():64-71. PubMed ID: 25818189
[TBL] [Abstract][Full Text] [Related]
25. Modulation of anxiety-like behavior by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray.
Almeida-Santos AF; Gobira PH; Rosa LC; Guimaraes FS; Moreira FA; Aguiar DC
Behav Brain Res; 2013 Sep; 252():10-7. PubMed ID: 23714073
[TBL] [Abstract][Full Text] [Related]
26. Depolarizing and calcium-mobilizing stimuli fail to enhance synthesis and release of endocannabinoids from rat brain cerebral cortex slices.
Sarmad S; Alexander SP; Barrett DA; Marsden CA; Kendall DA
J Neurochem; 2011 May; 117(4):665-77. PubMed ID: 21375532
[TBL] [Abstract][Full Text] [Related]
27. A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation.
Dinh TP; Freund TF; Piomelli D
Chem Phys Lipids; 2002 Dec; 121(1-2):149-58. PubMed ID: 12505697
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants and changes in concentration of endocannabinoids and N-acylethanolamines in rat brain structures.
Smaga I; Bystrowska B; Gawliński D; Pomierny B; Stankowicz P; Filip M
Neurotox Res; 2014 Aug; 26(2):190-206. PubMed ID: 24652522
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological inhibition of MAGL attenuates experimental colon carcinogenesis.
Pagano E; Borrelli F; Orlando P; Romano B; Monti M; Morbidelli L; Aviello G; Imperatore R; Capasso R; Piscitelli F; Buono L; Di Marzo V; Izzo AA
Pharmacol Res; 2017 May; 119():227-236. PubMed ID: 28193521
[TBL] [Abstract][Full Text] [Related]
30. Over-expression of monoacylglycerol lipase (MGL) in small intestine alters endocannabinoid levels and whole body energy balance, resulting in obesity.
Chon SH; Douglass JD; Zhou YX; Malik N; Dixon JL; Brinker A; Quadro L; Storch J
PLoS One; 2012; 7(8):e43962. PubMed ID: 22937137
[TBL] [Abstract][Full Text] [Related]
31. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes.
Saario SM; Savinainen JR; Laitinen JT; Järvinen T; Niemi R
Biochem Pharmacol; 2004 Apr; 67(7):1381-7. PubMed ID: 15013854
[TBL] [Abstract][Full Text] [Related]
32. Assay of Monoacylglycerol Lipase Activity.
Jung KM; Piomelli D
Methods Mol Biol; 2023; 2576():285-297. PubMed ID: 36152196
[TBL] [Abstract][Full Text] [Related]
33. Disulfiram is an inhibitor of human purified monoacylglycerol lipase, the enzyme regulating 2-arachidonoylglycerol signaling.
Labar G; Bauvois C; Muccioli GG; Wouters J; Lambert DM
Chembiochem; 2007 Jul; 8(11):1293-7. PubMed ID: 17579916
[TBL] [Abstract][Full Text] [Related]
34. A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol.
Blankman JL; Simon GM; Cravatt BF
Chem Biol; 2007 Dec; 14(12):1347-56. PubMed ID: 18096503
[TBL] [Abstract][Full Text] [Related]
35. An endocannabinoid mechanism for stress-induced analgesia.
Hohmann AG; Suplita RL; Bolton NM; Neely MH; Fegley D; Mangieri R; Krey JF; Walker JM; Holmes PV; Crystal JD; Duranti A; Tontini A; Mor M; Tarzia G; Piomelli D
Nature; 2005 Jun; 435(7045):1108-12. PubMed ID: 15973410
[TBL] [Abstract][Full Text] [Related]
36. Endocannabinoids at the spinal level regulate, but do not mediate, nonopioid stress-induced analgesia.
Suplita RL; Gutierrez T; Fegley D; Piomelli D; Hohmann AG
Neuropharmacology; 2006 Mar; 50(3):372-9. PubMed ID: 16316669
[TBL] [Abstract][Full Text] [Related]
37. Monoglyceride lipase: Structure and inhibitors.
Scalvini L; Piomelli D; Mor M
Chem Phys Lipids; 2016 May; 197():13-24. PubMed ID: 26216043
[TBL] [Abstract][Full Text] [Related]
38. Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB₁ and CB₂ receptors.
Desroches J; Charron S; Bouchard JF; Beaulieu P
Neuropharmacology; 2014 Feb; 77():441-52. PubMed ID: 24148808
[TBL] [Abstract][Full Text] [Related]
39. 2-AG + 2 new players = forecast for therapeutic advances.
Marrs W; Stella N
Chem Biol; 2007 Dec; 14(12):1309-11. PubMed ID: 18096497
[TBL] [Abstract][Full Text] [Related]
40. Discovery and development of endocannabinoid-hydrolyzing enzyme inhibitors.
Minkkilä A; Saario S; Nevalainen T
Curr Top Med Chem; 2010; 10(8):828-58. PubMed ID: 20370710
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
